The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models.
Flanigan
Sara A
SA
Developmental Therapeutic Program, University of Colorado, 12801 E. 17th Avenue, Aurora, CO 80045, USA.
Pitts
Todd M
TM
Eckhardt
S Gail
SG
Tentler
John J
JJ
Tan
Aik Choon
AC
Thorburn
Andrew
A
Leong
Stephen
S